Evidence Based Medicine: Recommendations for Pharmacological Treatment of Osteoarthritis Patients

作者: Tonko Vlak , Simeon Grazio , Božidar Ćurković , Branko Kopjar

DOI:

关键词:

摘要: Nesteroidni antireumatici (NSAR) lijek su izbora u lijecenju boli bolesnika s osteoartritisom (OA). Velik broj razlicitih NSAR dostupnih na tržistu otežava izbor pojedinoga. Cilj rada: Kriticki pregledati tri tipa podataka koji se odnose (rezultati istraživanja, klinicko iskustvo i troskovi), radi davanja preporuka kao pomoc pri odlucivanju o terapiji. Materijali metode: Pretražene Cochrane, Medline Embase baze za pregledne clanke kontrolirana randomizirana ispitivanja klinickoj djelotvornosti nuspojavama NSAR. Klinicko temelji stavovima lijecnika-klinicara koautora rada. Podaci troskovima prodaji hrvatsko tržiste. Rezultati: Svi NSAR, ukljucujuci COX-2 selektivne inhibitore, imaju slicnu djelotvornost kontroli OA boli. Stetni ucinak gornji dio probavnoga trakta najmanji je diklofenak ibuprofen, dok iako vjerojatno manji, nije potpuno utvrđen. Ostale nuspojave rijetko znacenje, a inhibitore jos nisu dovoljno istražene. Dugogodisnje povoljno postoji diklofenakom ibuprofenom. Najniži troskovi lijecenja diklofenak, selektivni inhibitori znatno skuplji od neselektivnih Zakljucak: Diklofenak, potom ibuprofen ostaju prvi farmakoloskog OA.

参考文章(30)
Gioacchino Leandro, Alberto Pilotto, Marilisa Franceschi, Tosca Bertin, Emanuela Lichino, Francesco Di Mario, Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Digestive Diseases and Sciences. ,vol. 46, pp. 1924- 1936 ,(2001) , 10.1023/A:1010687115298
Kaplan D, Malamet R, Forman, A survey of osteoarthritis of the knee in the elderly. The Journal of Rheumatology. ,vol. 10, pp. 282- 287 ,(1983)
Vivian Welch, Catherine Dube, Peter Tugwell, George Wells, Jessie Mcgowan, Alaa Rostom, The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials. The Journal of Rheumatology. ,vol. 27, pp. 2203- 2214 ,(2000)
Aram V. Manoukian, Jeffrey L. Carson, Nonsteroidal anti-inflammatory drug-induced hepatic disorders : Incidence and prevention Drug Safety. ,vol. 15, pp. 64- 71 ,(1996) , 10.2165/00002018-199615010-00005
P. C. Gøtzsche, Meta-analysis of NSAIDs: contribution of drugs, doses, trial designs, and meta-analytic techniques. Scandinavian Journal of Rheumatology. ,vol. 22, pp. 255- 260 ,(1993) , 10.3109/03009749309095135
Francesca Catella-Lawson, Leslie J Crofford, Cyclooxygenase inhibition and thrombogenicity. The American Journal of Medicine. ,vol. 110, pp. 28- 32 ,(2001) , 10.1016/S0002-9343(00)00683-5
T.C. CHALMERS, J. BERRIER, P. HEWITT, J. BERLIN, D. REITMAN, R. NAGALINGAM, H. SACKS, Meta-analysis of randomized controlled trials as a method of estimating rare complications of non-steroidal anti-inflammatory drug therapy. Alimentary Pharmacology & Therapeutics. ,vol. 2, pp. 9- 26 ,(2007) , 10.1111/J.1365-2036.1988.TB00761.X
Grant W. Cannon, Jacques R. Caldwell, Peter Holt, Barry McLean, Beth Seidenberg, James Bolognese, Elliot Ehrich, Suarabh Mukhopadhyay, Brian Daniels, Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one‐year, randomized, clinical trial in patients with osteoarthritis of the knee and hip Arthritis & Rheumatism. ,vol. 43, pp. 978- 987 ,(2000) , 10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0